38:
221:
457:
29:
50:
501:
308:
378:. It is used as one of a few experimental treatments for patients with deadly pancreatic cancer when the main chemotherapeutic treatment regimen of
520:
494:
535:
555:
545:
328:
294:
487:
530:
74:
160:
200:
550:
525:
189:
540:
216:
467:
95:
37:
433:
371:
237:
169:
149:
104:
220:
471:
375:
400:
514:
464:
456:
129:
379:
270:
140:
437:
20:
28:
115:
336:
InChI=1S/C3H7N3O4/c4-2(3(7)8)1-6(10)5-9/h2,10H,1,4H2,(H,7,8)/t2-/m0/s1
180:
293:
284:
370:) is a substance that has been studied for the treatment of
205:
475:
353:
282:
269:
236:
231:
199:
179:
159:
139:
114:
94:
65:
49:
44:
128:
103:
495:
8:
19:
502:
488:
424:Yu J (November 2001). "Alanosine (UCSD)".
219:
148:
168:
426:Current Opinion in Investigational Drugs
391:
333:
313:
215:
79:
18:
188:
7:
453:
451:
119:
14:
455:
254:
248:
36:
27:
341:Key:MLFKVJCWGUZWNV-REOHCLBHSA-N
521:Drugs not assigned an ATC code
260:
242:
1:
474:. You can help Knowledge by
572:
536:2,3-Diaminopropionic acids
450:
232:Chemical and physical data
86:)-2-Amino-3-propanoic acid
556:Antiinfective agent stubs
546:Experimental cancer drugs
349:
324:
304:
70:
35:
26:
405:pubchem.ncbi.nlm.nih.gov
531:Amino acid derivatives
382:is no longer useful.
23:
551:Toxic amino acids
483:
482:
372:pancreatic cancer
361:
360:
316:O=C(O)(N)CN(O)N=O
295:Interactive image
201:CompTox Dashboard
16:Chemical compound
563:
504:
497:
490:
459:
452:
442:
441:
421:
415:
414:
412:
411:
396:
357:
356:
297:
277:
262:
256:
250:
244:
224:
223:
209:
207:
192:
172:
152:
132:
122:
121:
107:
40:
31:
24:
22:
571:
570:
566:
565:
564:
562:
561:
560:
526:Antimetabolites
511:
510:
509:
508:
448:
446:
445:
432:(11): 1623–30.
423:
422:
418:
409:
407:
398:
397:
393:
388:
352:
350:
345:
342:
337:
332:
331:
320:
317:
312:
311:
300:
275:
265:
259:
253:
247:
227:
217:DTXSID501024175
203:
195:
175:
155:
135:
118:
110:
90:
87:
78:
77:
61:
17:
12:
11:
5:
569:
567:
559:
558:
553:
548:
543:
538:
533:
528:
523:
513:
512:
507:
506:
499:
492:
484:
481:
480:
460:
444:
443:
416:
390:
389:
387:
384:
376:antimetabolite
359:
358:
347:
346:
344:
343:
340:
338:
335:
327:
326:
325:
322:
321:
319:
318:
315:
307:
306:
305:
302:
301:
299:
298:
290:
288:
280:
279:
273:
267:
266:
263:
257:
251:
245:
240:
234:
233:
229:
228:
226:
225:
212:
210:
197:
196:
194:
193:
185:
183:
177:
176:
174:
173:
165:
163:
157:
156:
154:
153:
145:
143:
137:
136:
134:
133:
125:
123:
112:
111:
109:
108:
100:
98:
92:
91:
89:
88:
81:
73:
72:
71:
68:
67:
63:
62:
60:
59:
55:
53:
47:
46:
42:
41:
33:
32:
15:
13:
10:
9:
6:
4:
3:
2:
568:
557:
554:
552:
549:
547:
544:
542:
539:
537:
534:
532:
529:
527:
524:
522:
519:
518:
516:
505:
500:
498:
493:
491:
486:
485:
479:
477:
473:
470:article is a
469:
466:
465:antiinfective
461:
458:
454:
449:
439:
435:
431:
427:
420:
417:
406:
402:
395:
392:
385:
383:
381:
377:
373:
369:
366:(also called
365:
355:
348:
339:
334:
330:
323:
314:
310:
303:
296:
292:
291:
289:
286:
281:
274:
272:
268:
241:
239:
235:
230:
222:
218:
214:
213:
211:
202:
198:
191:
187:
186:
184:
182:
178:
171:
167:
166:
164:
162:
158:
151:
147:
146:
144:
142:
138:
131:
127:
126:
124:
117:
113:
106:
102:
101:
99:
97:
93:
85:
80:
76:
69:
64:
57:
56:
54:
52:
48:
45:Clinical data
43:
39:
34:
30:
25:
541:Nitrosamines
476:expanding it
462:
447:
429:
425:
419:
408:. Retrieved
404:
394:
367:
363:
362:
351:
190:ChEMBL452715
83:
401:"Alanosine"
380:gemcitabine
374:. It is an
278: g·mol
66:Identifiers
515:Categories
410:2021-04-08
386:References
283:3D model (
271:Molar mass
170:2CNI71214Y
141:ChemSpider
96:CAS Number
75:IUPAC name
399:PubChem.
364:Alanosine
105:5854-93-3
21:Alanosine
438:11763167
354:(verify)
51:ATC code
368:SDX-102
276:149.106
238:Formula
116:PubChem
436:
309:SMILES
181:ChEMBL
463:This
329:InChI
285:JSmol
150:20787
130:22128
472:stub
468:drug
434:PMID
161:UNII
58:None
206:EPA
120:CID
517::
428:.
403:.
503:e
496:t
489:v
478:.
440:.
430:2
413:.
287:)
264:4
261:O
258:3
255:N
252:7
249:H
246:3
243:C
208:)
204:(
84:S
82:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
